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The efficacy of infection control interventions against Acinetobacter baumannii remains unclear, despite such
information being critical for effective prevention of the transmission of this pathogen. Mathematical modeling offers
an alternative to clinical trials, which may be prohibitively expensive, unfeasible or unethical, in predicting the impact of
interventions. Furthermore, it allows the ability to ask key “what if” questions to evaluate which interventions have the
most impact. We constructed a transmission dynamic model to quantify the effects of interventions on reducing A.
baumannii prevalence and the basic reproduction ratio (R0) in intensive care units (ICUs). We distinguished between
colonization and infection, and incorporated antibiotic exposure and transmission from free-living bacteria in the
environment. Under the assumptions and parameterization in our model, 25% and 18% of patients are colonized and
infected with A. baumannii, respectively; and R0 is 1.4. Improved compliance with hand hygiene (87%), enhanced
environmental cleaning, reduced length of ICU stay of colonized patients ( 10 days), shorter durations of antibiotic
treatment of A. baumannii (6 days), and isolation of infected patients combined with cleaning of isolation rooms are
effective, reducing R0 to below unity. In contrast, expediting the recovery of the intestinal microbiota (e.g. use of
probiotics) is not effective. This study represents a biologically realistic model of the transmission dynamics of A.
baumannii, and the most comprehensive analysis of the effectiveness of interventions against this pathogen. Our study
provides important data for designing effective infection control interventions.
Introduction
Acinetobacter baumannii is a leading cause of severe infections,
such as ventilator-associated pneumonia, bacteremia, urinary
tract infections and meningitis, in patients in intensive care units
(ICUs).1 Infections caused by A. baumannii are difficult to treat
because it is resistant to many antibiotics.2 As such, limiting the
emergence and spread of this pathogen is of paramount
importance.
The acquisition and spread of A. baumannii is a complex
and dynamic process determined by various inter-related fac-
tors. Exposure to antibiotics and the resultant disruption of
the intestinal microbiota are known to predispose to A. bau-
mannii acquisition.3 Other major contributing factors for the
acquisition of A. baumannii in ICUs include patient-related
factors such as use of invasive procedures, and ICU-related
factors such as transmission between patients within the
ward (cross-transmission).4,5 Furthermore, A. baumannii can
remain viable in the hospital environment for a prolonged
period of time, serving as an important reservoir and contrib-
uting to acquisition by susceptible patients (environment-
patient transmission).6,7 As such, a multifaceted approach
which encompasses reducing cross-transmission, environment-
patient transmission and antibiotic exposure could be
required to limit the acquisition and spread of this pathogen.
However, the relative contribution of each component
remains unclear. Historically, such data can be obtained by
conducting clinical and epidemiological studies. However,
these studies are time-consuming and may be prohibitively
expensive in the hospital setting. Operational and/or ethical
constraints may further limit whether interventions can be
evaluated in clinical studies. Additionally, these studies are
inherently unable to capture the interdependence between
individuals. As such, these studies only provide individual
patient-level data and fail to fully characterize the transmis-
sion dynamics of the pathogen.
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Population-level mathematical models, by providing a theo-
retical framework to conceptualize the dynamic interactions
between interdependent variables, can overcome the aforemen-
tioned challenges.8 They provide important insights into the
underlying dynamics of an infection; and enable us to quantify
the potential impact of various interventions without conducting
those interventions.8 Mathematical models also allow us to test
“what-if” scenarios for the design of optimal intervention strate-
gies.8 While various models have investigated the effects of inter-
ventions against Gram-positive pathogens;9-12 data on the
population-level impact of interventions against A. baumannii
(and other Gram-negative organisms alike) are scant. To date,
there are only 2 modeling studies that investigate the transmis-
sion dynamics of A. baumannii.4,7 Although both studies provide
important insight into the spread of this pathogen, they have lim-
itations. In our previous model, environment and interventions
were not considered;4 whereas the model by Wang et al.7 did not
distinguish between colonization and infection, nor did it take
into account the effects of antibiotic exposure. Furthermore,
nurse cohorting and nurse-patient ratio were the only interven-
tions investigated in Wang et al.7
Consequently, we have developed a comprehensive mechanis-
tic model to describe the transmission dynamics of A. baumannii
in ICUs, and to quantify the effects of various interventions on
reducing A. baumannii transmission. Unlike most previous mod-
els,9-11,13,14 we have differentiated between patients colonized
and infected with A. baumannii, and incorporated the important
role of antibiotic exposure and free-living bacteria in the
environment.
Materials and Methods
Mechanistic transmission dynamic
model
A mechanistic model was developed to
describe the transmission dynamics of A.
baumannii in a hypothetical 100-bed
ICU (Fig. 1). In this model, patients
were in 5 mutually exclusive states
according to their infection status:
uncolonized without or with antibiotic
exposure (U and UA, respectively), colo-
nized without or with antibiotic exposure
(C and CA, respectively), or clinically
infected (I). Antibiotic exposure was
defined as currently receiving any sys-
temic antibiotic or having received antibi-
otics within the last 30 d.15 Colonized
and infected patients harbor the patho-
gen; however only infected patients mani-
fest clinical symptoms. Patients could be
admitted to the ICU in any of these 5
states. Of new admissions, 57.6% and
36.8% were uncolonized without and
with antibiotic exposure, respectively;16
and 0.3% and 5.3% were colonized with-
out and with antibiotic exposure, respec-
tively.16 New admissions that were already clinically infected
with A. baumannii were 0%.17 Patients could be discharged from
any compartment, except for the infected compartment where
they were manifesting symptoms.18 Discharge occurred at a rate
of g per day, calculated as the inverse of the length of ICU stay
(hereinafter referred to as length of stay, LoS) specific for each
compartment. Uncolonized and colonized patients, irrespective
of their antibiotic exposure status, stayed in the ICU for an aver-
age of 5.5 and 16.5 d, respectively.19-22 We assumed that the
ICU was fully occupied, and that new admissions balanced dis-
charges, resulting in a constant population size of N D U C UA
C C C CA C I D 100.4,12
The movement from uncolonized or colonized without anti-
biotic exposure (U, C, respectively) to the corresponding com-
partments with antibiotic exposure (UA, CA, respectively)
occurred at a rate of e D 0.12 per day (antibiotic prescribing
rate), which calibrated to 59.5% of ICU patients being pre-
scribed antibiotics (for reasons other than treatment of A. bau-
mannii infection) at any time during their stay.23,24 The reverse
process (moving from UA to U, and from CA to C) occurred
when a patient’s intestinal microbiota recovered after discontin-
uation of antibiotics, which was assumed to take 35 d.25 The
recovery rate of the intestinal microbiota, l, was calculated as
the inverse of this recovery time (l D 0.03 per day). The use of
probiotics was assumed to act by expediting this recovery
process.26
Uncolonized patients could become colonized via cross-trans-
mission between patients within the ICU. This acquisition
process was determined by the cross-transmission coefficient,
Figure 1. A compartmental model describing the transmission dynamics of A. baumannii in an
intensive care unit. The solid arrows represent entry to and exit from the 5 compartments: C, colo-
nized without antibiotic exposure; CA, colonized with antibiotic exposure; I, infected; U, uncolonized
without antibiotic exposure; UA, uncolonized with antibiotic exposure. The broken arrows represent
the shed of bacteria into the environment (E) from colonized and infected patients, and the trans-
mission from free-living bacteria in the environment to susceptible (uncolonized) patients.
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b D 50 £ 10¡4 per colonized per susceptible per day, which was
estimated in our previous model.4 This cross-transmission coeffi-
cient incorporates both direct transmission between patients and
transmission between patients via transiently contaminated hands
of healthcare workers.4 Of note, the latter is responsible for most
cross-transmission because ICU patients are not moving in the
ward.4 Cross-transmission could be reduced by improving the
rate of compliance with hand hygiene, h, which was 82% at base-
line.27 Hand hygiene was assumed to be 100% effective.28
Uncolonized patients with antibiotic exposure (UA) were
assumed to be 1.67 times more susceptible than uncolonized
patients without antibiotic exposure (U); whereas colonized
patients with antibiotic exposure (CA) and infected patients (I)
were assumed, respectively, to be 1.67 and 2 times more infec-
tious than colonized patients without antibiotic exposure (i.e.
infectivity of CA relative to C, V1 D 1.67; infectivity of I relative
to C, V2 D 2).29
Colonized and infected patients shed bacteria into the
environment (i.e., ICU), which could survive for a prolonged
period of time, serving as another important source of trans-
mission (environment-patient transmission). This transmis-
sion process was determined by the environment-patient
transmission coefficient, z D 4 £ 10¡6 (per colony-forming
unit [CFU] per susceptible per day).30 Hand hygiene among
healthcare workers or cleaning of the ICU (environmental
cleaning), which occurred at a rate of r D 0.7 per day, would
reduce this transmission source.30 Environmental cleaning
was assumed to eradicate 55% of the bacteria (environmental
cleaning efficacy, a).31 Free-living bacteria were assumed to
be uniformly distributed in the environment and modeled in
our study as another compartment (E).30
Colonized patients with antibiotic exposure became infected
(movement from CA to I) at a rate of uA D 0.11 per day.5 Colo-
nized patients without antibiotic exposure were assumed to be 5-
times less likely to become infected than those with antibiotic
exposure.32 Antibiotic treatment of patients infected with A. bau-
mannii was assumed to take 13 d (t¡1 D 13) with a successful
clearance rate of s D 0.76 per treated patient.33,34 Infected
patients who were successfully treated and cleared of the patho-
gen returned to the uncolonized with antibiotic exposure com-
partment; whereas the remaining treated patients returned to the
colonized with antibiotic exposure compartment. Fifteen percent
Table 1. Baseline input values of model variables
Variable Definition (unit) Baseline value Reference
e Antibiotic prescribing rate (/day)a 0.12 23,24
l Recovery rate of intestinal microbiota (/day) 0.03 25
b Cross-transmission coefficient (/colonized/susceptible/day) 50 £ 10¡4 4
z Environment-patient transmission coefficient (/CFU/susceptible/day) 4 £ 10¡6 30
V1 Infectivity of CA relative to C 1.67 29
V2 Infectivity of I relative to C 2 29
uA Rate of CA becoming infected (symptom development rate) (/day) 0.11 5
u Rate of C becoming infected (symptom development rate) (/day) uA/5 32
t Treatment of A. baumannii infection (/day) (1/antibiotic treatment duration of infected patients) 0.08 33,34
s Treatment success rate of A. baumannii infection (/treated patient) 0.76 34
h Rate of self-resolution of symptoms (/day)b 0.018 35
f Fatality rate of infected patients (/day)c 0.016 36
r Environmental cleaning rate (/day) 0.70 30
a Efficacy of environmental cleaning (/CFU) 0.55 31
h Compliance with hand hygiene 0.82 27
gU, gUA Discharge rate of U and UA (/day) 0.18 19,20
gC, gCA Discharge rate of C and CA (/day) 0.06 21,22
L Admission rate (/day) Rate of leaving the ICUd
mU, mUA Proportion of U and UA on admission 57.6%; 36.8% 16
mC, mCA, mI Proportion of C, CA and I on admission 0.3%; 5.3%; 0% 16,17
F1, F2, F3 Bacterial density shed into the environment by C, CA and I (CFU/patient/day) 281; 470; 563 30
aCalibrates to 59.5% of patients receiving antibiotics any time during their ICU stay.
bCalibrates to 15% of infected patients having symptoms that self-resolve.
cCalibrates to 14% attributable mortality rate.
dAdmission rate, LD gUU C gAUAC gCCC gCACAC fI
C, colonized without antibiotic exposure; CA, colonized with antibiotic exposure; CFU, colony-forming unit; I, infected; ICU, intensive care unit; U, uncolonized
without antibiotic exposure; UA, uncolonized with antibiotic exposure.
Table 2. Variation range for variables evaluated in sensitivity analysis
Variable Symbol Range Reference
Treatment success rate of A.
baumannii infection
s 0.6–0.9 34
Rate of self-resolution of symptoms h 0.018–0.022 §10%
Cross-transmission coefficient b 39–71 £ 10¡4 4
Environment-patient transmission
coefficient
z 3.4–4.6 £ 10¡6 30
Fatality rate of infected patientsa f 0.006– 0.020 36,55
LoS of colonized patients g ¡ 1C 7–25 4,43
aCalibrates to 6% and 17% attributable mortality rate, respectively.
LoS, length of stay.
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of infected patients had self-resolving symptoms and returned to
the colonized with antibiotic exposure compartment;35 and 14%
of infected patients died as a result of the disease.36 Table 1 sum-
marizes the input values of the model variables with their defini-
tions and references. The system of ordinary differential
equations that describe the transition between compartments is
as follows:
dU
dt
DLmUC λUA ¡ Ub.1¡ h/.CCV1CA CV2I/
N
¡ gUU ¡ eU ¡ z.1¡ h/EU ;
dUA
dt
DLmUA C eU C stI ¡ UAb£ 1:67£ .1¡ h/.CCV1CA CV2I/
N
¡ λUA ¡ gUAUA ¡ z.1¡ h/EUA;
dC
dt
DLmCC λCA C Ub.1¡ h/.CCV1CA CV2I/
N
¡ eC¡ gCC¡ uCC z.1¡ h/EU ;
dCA
dt
DLmCA C eCC UAb£ 1:67£ .1¡ h/.CCV1CACV2I/
N
C .1¡ s/tI C hI ¡ gCACA¡ λCA ¡ uACA C z.1¡ h/EUA;
dI
dt
DLmIC uCC uACA ¡ fI ¡ hI ¡ stI ¡ .1¡ s/tI ;
dE
dt
DF1CCF2CA CF3I ¡ raE:
The model was simulated for one year (365 days). The follow-
ing outcome measures were estimated: prevalence of colonized
and infected patients, and the basic reproduction ratio, R0.
Briefly, R0 is the average number of secondary colonized cases
resulting from one single infectious individual in a totally suscep-
tible population.37 It is an important predictor of whether and
how quickly an infection will spread. The aim of any intervention
is to reduce R0 to below unity. The next generation matrix
method (described in Appendix 1) was used to estimate R0 in
our study.38
Interventions
Simulations were performed to evaluate the efficacy of various
interventions in reducing the prevalence of colonized and
infected patients, and R0. The following interventions were
investigated: (1) improved compliance with hand hygiene (h); (2)
reduced antibiotic prescribing rate (e); (3) reduced antibiotic
treatment duration in patients infected with A. baumannii
.t¡ 1/; (4) improved recovery rate of the intestinal microbiota (λ,
via use of probiotics); (5) reduced LoS of colonized patients
.g ¡ 1C / following evidence that LoS is a major risk factor for A.
baumannii;39 (6) increased environmental cleaning rate (r, more
frequent cleaning); (7) improved envi-
ronmental cleaning efficacy (a, e.g.,
more effective cleaning products, train-
ing for cleaning teams); and (8) isolation
of infected patients combined with
cleaning of isolation rooms.
Sensitivity analysis
Multivariate sensitivity analysis was
carried out to investigate the key drivers
of the outcome measures and the sensi-
tivity of model outputs to changes in
model inputs. The following variables
were assessed: success rate of A. bauman-
nii treatment (s), rate of self-resolution
of symptoms (h); cross-transmission
coefficient (b); environment-patient
transmission coefficient (z); fatality rate
of infected patients (f ); and LoS of colo-
nized patients .g ¡ 1C /. The range of each
variable is shown in Table 2. The Latin
hypercube sampling method was per-
formed. Partial rank correlation coeffi-
cients were calculated to evaluate theFigure 2. Prevalence of patients colonized and infected with A. baumannii at baseline.
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strength of the correlation
between each outcome measure
and each variable.40 All analysis
was performed using MATLAB
(version R2015a, MathWorks,
Natick, MA, USA). The differen-
tial equations were solved using
the ode45 solver.
Results
Baseline scenario
Using the baseline parameters
(Table 1), we estimate that 25%
of patients are colonized, and
18% are infected with A. bauman-
nii (Fig. 2). Acquisition is pre-
dominantly caused by within-
ward transmission (98%), rather
than colonization already present
on admission. R0 is estimated to
be 1.4.
The impact of interventions
Figure 3 shows the predicted
effects of individual interventions
on reducing the prevalence of A.
baumannii and R0. The relative
effects among the interventions
investigated are shown in Fig-
ure 4. Compliance with hand
hygiene (h) is the most effective
intervention whereby a modest
improvement in compliance rate,
from 82% (baseline) to 87%,
reduces R0 from 1.4 to unity, and
reduces the prevalence of colo-
nized and infected patients by 6%
(from 25% to 19%) and 4%
(from 18% to 14%), respectively
(Fig. 3A). In an idealized scenario
where compliance rate is 100%,
R0 is reduced to zero; however, A.
baumannii always persists at a low
level (Fig. 5A). This is because of
the constant admission of colo-
nized patients into the ICU, with
5.6% of admitted patients already
colonized at baseline. Figure 5A
shows that when colonized
patients are not admitted, A. baumannii will become extinct
when R0 is below unity. When R0 is above unity, A. baumannii is
always endemic irrespective of whether colonized patients are
admitted (Fig. 5B).
Frequent ward cleaning (r) is also an effective intervention
(Fig. 3B). Increasing environmental cleaning rate from 0.7 (base-
line) to 1 (daily cleaning) reduces the prevalence of colonized and
infected patients from 25% to 19% and from 18% to 14%,
respectively. Daily ward cleaning also reduces R0 to unity. Similar
Figure 3. Effects of individual interventions on the prevalence of colonization (long-dashed lines), infection
(short-dashed lines), total colonization and infection (solid lines), and the basic reproduction ratio, R0 (dotted
lines). The following interventions were investigated: compliance with hand hygiene (A), environmental
cleaning rate (B), environmental cleaning efficacy (C), length of stay of colonized patients (D), antibiotic pre-
scribing rate (E), treatment duration of infected patients (F), and recovery of intestinal microbiota (G).
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reductions can be achieved when the
efficacy of environmental cleaning
(a) is improved from 55% (base-
line) to 75% (Fig. 3C). Figures 6A
and B show the combined effects of
enhanced cleaning rate and cleaning
efficacy. Combining the 2 interven-
tions yields improved benefits com-
pared to each intervention alone.
For example, daily ward cleaning
combined with improved cleaning
efficacy (from 55% to 75%) reduces
the total prevalence of colonization
and infection by 18%, compared to
10–11% reduction achievable with
each intervention alone. Isolation of
infected patients has modest effects
(Fig. 4). However, isolation com-
bined with cleaning of isolation
rooms is effective, significantly
reducing the prevalence of colonized
patients from 25% (baseline) to
14%, and the prevalence of infected
patients from 18% (baseline) to
11%. With this strategy, R0 is 0.7
(Fig. 4).
Figure 3D shows the effects of
reducing the LoS of colonized
patients .g ¡ 1C /. The prevalence of
A. baumannii decreases with shorter
LoS (increased discharge rate). Spe-
cifically, when the LoS is reduced
from the baseline of 16.5 d to
10 days, R0 reduces to below unity,
and the prevalence of colonization
and infection reduces by 7% (from
25% to 18%) and 5% (from 18%
to 13%), respectively.
When antibiotic prescribing rate
(e) among ICU patients (for rea-
sons other than treatment of A.
baumannii infection) and antibi-
otic treatment duration of infected
patients .t¡ 1/ are investigated sep-
arately, only the latter is effective.
Reducing antibiotic prescribing
rate from 0.12 (baseline) to 0 (no
antibiotic use) only results in a 4%
reduction in the total prevalence of
colonized and infected patients
(Fig. 3E). In contrast, similar
reductions in antibiotic treatment
duration of infected patients (t¡ 1,
from 13 d to 5 days) decrease the
total prevalence of colonized and
infected patients by 14% (from
Figure 4. Relative effects of different interventions on the total prevalence of colonized and infected
patients (A), and the basic reproduction ratio, R0 (B).
Figure 5. Prevalence of A. baumanniiwhen the basic reproduction ratio, R0< 1 (A) and R0> 1 (B). When R0<1, A.
baumannii persists when colonized and infected patients are admitted (solid lines), and will die out if there is no
admission of colonized and infected patients (broken lines). When R0>1, A. baumannii always persists, once it has
been introduced into theward, irrespective of whether colonized and infected patients are admitted.
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43% to 29%) and R0 to unity
(Fig. 3F). This intervention has
greater effects on the prevalence
of infected patients than on colo-
nized patients because it specifi-
cally targets the former (Fig. 3F).
Combining the 2 interventions
fails to yield any improvements in
reducing A. baumannii preva-
lence compared to each interven-
tion alone (Figs. 6C and D). For
example, simultaneously reducing
antibiotic prescribing rate from
0.12 to 0 and antibiotic treatment
duration of infected patients from
13 d to 5 d only results in a 14%
reduction in the total prevalence
of colonized and infected
patients. Comparable reduction
would be achievable with reduced
antibiotic treatment duration of
infected patients alone.
The use of probiotics to expe-
dite the recovery of the intestinal
microbiota (l, 1/recovery time) is
not effective. Reducing the recov-
ery time from 35 d to 14 d only
reduces the total prevalence of
colonization and infection by 1%
(Fig. 3G). No enhanced effects
are achieved when probiotics are
used in conjunction with reduced
antibiotic prescribing rate (Fig-
s. 6E and F).
Varying transmission
coefficients
Figure 7 shows the effects of
varying the cross-transmission
coefficient (b) or environment-
patient transmission coefficient
(z) on the prevalence of A. baumannii and R0. Contaminated
environment is the predominant acquisition source compared to
cross-transmission. Complete elimination of environment-
patient transmission (z D 0) generates substantial benefits, reduc-
ing the prevalence of colonization from 25% to 7% and infection
from 18% to 6%. Eliminating this transmission source reduces
R0 to zero. In contrast, only modest impact occurs when cross-
transmission is limited.
Sensitivity analysis
Figure 8 shows the sensitivity of the outcome measures to
changes in model inputs. The outcome measures are most sensi-
tive to LoS of colonized patients .g ¡ 1C /, A. baumannii treatment
success rate (s), environment-patient transmission coefficient (z)
and fatality rate of infected patients (f ). The correlation coeffi-
cients are shown in Table 3.
Discussion
Our study represents the most comprehensive transmission
dynamic model for A. baumannii. Unlike previous studies,7,9-11,13,14,41
we differentiated between colonized and infected patients because
of their differences in clinical characteristics, particularly in path-
ogenesis, infectivity and infection control management. Under
the baseline values found from review of the literature, we predict
that A. baumannii is likely to be endemic in ICUs. The estimated
prevalence of colonization and infection is 25% and 18%, respec-
tively. Although we did not calibrate our model to any outcome
Figure 6. Effects of different combinations of interventions on the total prevalence of colonization and infec-
tion (A, C, E), and the basic reproduction ratio, R0 (B, D, F).
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values, our estimates are comparable with the mean values of the
prevalence of A. baumannii colonization (21%)4,16,42,43 and
infection (16%)5,42,44 reported in the literature. We found that
A. baumannii transmission continues even when R0 is below
unity owing to admission of already colonized patients to the
ICU. Our finding suggests that active screening on admission
and subsequent isolation of positive cases is an essential compo-
nent of any infection control policy to eliminate the transmission
of this pathogen. Although this strategy may be effective in con-
trolling A. baumannii, active screening is currently not in place
in most hospitals worldwide. This may be due in part to concerns
about the high costs of implementing such programs.8 Neverthe-
less, a comprehensive cost-effectiveness analysis of active screen-
ing programs is needed.
Hand hygiene is the most effective intervention in our
study because it limits both the transmission between patients
and, between patients and the environment. The rate of com-
pliance with hand hygiene was set at 82% at baseline in line
with Australian data.27 Although it is effective, inexpensive
and simple, compliance with hand hygiene remains obstinately
low in some settings, with estimated compliance rates as low
as 50%.45 When this compliance rate was considered, the
prevalence of colonization, infection, and R0 were estimated to
be 44%, 31%, and 3.7, respectively. Using Figure 3A, predic-
tions of A. baumannii prevalence and R0 could be obtained for
any level of hand hygiene compliance. Our model predicts
that a modest improvement in compliance rate, from 82% to
87%, will reduce R0 to below unity. Previous studies have
shown that such improvements would be achievable with
increased education and training, increased availability of alco-
hol-based hand rubs, workplace reminders, and performance
feedback.45
Our model also shows that
shorter durations of antibiotic
treatment in patients infected with
A. baumannii are associated with
lower prevalence of A. baumannii.
This suggests that treating patients
as quickly and effectively as possible
may be an effective strategy.
Indeed, previous clinical studies
have shown that the durations of
antibiotic therapy could be safely
reduced to 7 d based on clinical,
laboratory and radiologic measures
without any adverse effects on
patient’s outcomes while reducing
the prevalence of infection and
resistance.46-48 These findings
emphasize the importance of effec-
tive antimicrobial stewardship pro-
grams in reducing the duration of
antibiotic therapy. However, it
should be noted that the translation
of the findings of these studies into
clinical practice is currently
unknown; and that the optimal durations of antibiotic treatment
for many common infections remain to be established. Effective
antimicrobial stewardship programs can also lead to reductions
in antibiotic usage.49 However, we found that reducing antibiotic
prescribing rate among patients who are not infected with A. bau-
mannii has a modest impact on A. baumannii prevalence, consis-
tent with previous studies.12,18 This is because this strategy only
targets the small subset of patients who are uncolonized or colo-
nized without prior antibiotic exposure in our model.
Clinical evidence on the efficacy of probiotics in reducing
infections is inconclusive. It has been shown to be beneficial in
some studies;50 while others have shown minimal effects.51 Our
model suggests that using probiotics has a modest impact on the
population-level transmission dynamics of A. baumannii, consis-
tent with previous clinical studies.51 Nevertheless, our finding
does not necessarily negate the health benefits of these products
on an individual-patient level.26
We found that reducing LoS is effective in attenuating A. bau-
mannii, in support of evidence from clinical studies and previous
models.10,18,52 This is because this strategy reduces patient’s risk
factors for acquiring A. baumannii in the ICU.16 Our finding is
in contrast with Cooper et al.28 who demonstrated in their
model that shorter LoS resulted in higher within-ward coloniza-
tion.28 This may be explained by the increased number of suscep-
tible patients admitted to the ward as a result of reduced LoS
(increased discharge rate). Nevertheless, it should be noted that
LoS of patients should be based on their clinical characteristics
and response to treatment. As such, reducing LoS is likely to be
impractical in reality.
The current model incorporates transmission from free-living
bacteria in the environment, which has been ignored in the
majority of previous models.4,9-12,18,53 We found that
Figure 7. Effects of varying cross-transmission coefficient (b) and environment-transmission coefficient (z)
on the prevalence of colonization and infection (A), and the basic reproduction ratio, R0 (B). b and z were
set at 50 £ 10¡4 and 4 £ 10¡6 at baseline, respectively.
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contaminated environment is the major source of acquisition.
Our finding reinforces the importance of environmental cleaning
in controlling health-care associated infections as previously
shown in clinical studies.31,54 We found that improving the
effectiveness of environmental cleaning would substantially
reduce A. baumannii. This could be achieved by using more
effective cleaning products, training and monitoring the efficacy
of decontamination with feedback to cleaning teams. In our
Figure 8. Sensitivity analysis.
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model, free-living bacteria in the ICU were assumed to be uni-
formly distributed. In fact, bacterial density may be different
between places in the ICU (e.g., environment around infectious
patients versus computer keyboards or door knobs). Future mod-
els that take into account such heterogeneity in contamination
status are needed. Direct transmission between patients and free-
living bacteria in the environment should also be considered in
future studies.
Our study represents a biologically realistic model for the
transmission dynamics of A. baumannii in ICUs. It provides a
comprehensive analysis of the impact of interventions against this
pathogen. We have incorporated crucial factors to the epidemiol-
ogy of this pathogen such as antibiotic exposure, transmission
from contaminated environment and, distinguishing coloniza-
tion and infection. Like most biologically realistic simulation
models, we were unable to simulate a specific setting because
there is no single clinical study that provides complete parameter-
ization for our model. Importantly, our model provides a frame-
work that can be easily adjusted when such studies become
available. Given that the epidemiology of A. baumannii varies
considerably over time and between different settings, the inten-
tion of our model is not to provide numerical estimates that
apply to every setting. However, our model can be adjusted to
incorporate institution-specific data to guide infection control.
Our model can be modified to integrate greater complexity such
as co-morbidities, immune status, antibiotic resistance, co-infec-
tion with other pathogens, and the effects of stochasticity.
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Appendix 1 The next generation matrix for estimating the basic reproduction number, R0
The next generation matrix method involves linearizing the original nonlinear ordinary differential equations at disease-free equi-
librium.38 At the disease-free equilibrium, X*, the numbers of individuals in each compartment are given by:
X D UD ¡ λN ¡ gUANmU
gUmU¡ gUAmU¡ λ¡ gU¡ e
; UA DN ¡U; CD 0; CA D 0; ID 0
 
:
Let F be the transmission matrix, describing the production of new infections; and V be the transition matrix, describing changes in
state (including removal by discharge or death). F and V are defined as follows:
FD @Fi.X /
@Xj
 
X DX 
and V D @Vi.X /
@Xj
 
X DX 
where Fi(X) is the number of new infections in the i
th compartment from Xj infectious individuals; and Vi(X) is the net change of indi-
viduals in the ith compartment by any other means. The rates are evaluated at the disease-free equilibrium, X*. The next generation
matrix, K, is then given by K D ¡FV¡1. The (i,j) element of the K matrix represents the number of secondary infected cases in com-
partment i produced by individuals in compartment j. The basic reproduction number, R0, is given by the spectral radius of the K
matrix.
For our model, the transmission and transition matrices in the case with only cross-transmission between patients (FP and VP,
respectively) are given by:
FPD
Ub.1¡ h/
N
Ub.1¡ h/V1
N
Ub.1¡ h/V2
N
UAb£ 1:67£ .1¡ h/
N
UAb£ 1:67£ .1¡ h/V1
N
UAb£ 1:67£ .1¡ h/V2
N
0 0 0
2
6664
3
7775;
VPD
¡ .gCC uC e/ λ 0
e ¡ .gCA C uAC λ/ .1¡ s/tC h
u uA ¡ .f C tC h/
2
4
3
5:
The next generation matrix with only cross-transmission is then given by KPD ¡FPV ¡ 1P .
The transmission and transition matrices in the case with only environment-patient transmission (FE and VE, respectively) are
given by:
FED
zU.1¡ h/
zUA.1¡ h/
0
2
4
3
5; VED ¡ ra½ :
The next generation matrix with only environment-patient transmission, KE, is then given by
KEDFEV ¡ 1E F1 F2 F3½  V ¡ 1P :
The next generation matrix of the model is then given by K DKPCKE; and R0 is given by the spectral radius of the K matrix. The
high-dimension of the K matrix makes analytical solution for R0 intractable. R0 therefore was derived numerically in our model.
Detailed discussion of the next generation matrix method for compartmental epidemic models can be found in Diekmann et al.38
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